Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.
In this article
Kimberly-Clark
said on Monday it will buy Tylenol-maker Kenvue
in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States.
Shares of Kenvue were up 18% in premarket trading, while Kimberly-Clark’s shares were down 12.5%.
Kimberly-Clark agrees to purchase Kenvue for $48.7B - UPI.com
Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal
Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal
Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Ultima ora - Ansa.it
Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Notizie - Ansa.it
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
Huggies Maker Buys Kenvue (Tylenol Maker) For $48 Billion
El dueño de Kleenex compra la empresa de Tylenol y Neutrógena por casi 35.000 millones
Kimberly-Clark swoops on Tylenol maker Kenvue as US deal spree accelerates
